Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Thrombosis
Study data from Johns Hopkins University, Medical Department update understanding of thrombosis
June 15th, 2009
According to a study from the United States, "We sought. to determine the outcomes in patients presenting with venous thoracic outlet syndrome. Prospectively collected data from 67 patients between October 2003 and December 2007." "The average age was 31 years (range, 16-54); the 3 7 males and 30 females presented on average 9.2 months (range, 1 month-6 years) after acute thrombosis. Four treatment algorithms were utilized. In. group 1, 3 patients presented with acute occlusion and received tissue plasminogen activator (tPA) and immediate first rib resection with scalenectomy (FRRS). One vein rethrombosed and was treated by intravenous IPA postoperatively. In group 2,...
Source: Biotech Business Week (2009-06-15)
|
